TrialAutoimmunity1994

Influence of FK 506 (tacrolimus) on circulating CD4+ T cells expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trial.

B Lemster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.